Germany rejects US-backed proposal to waive vaccine patents

Germany rejects US-backed proposal to waive vaccine patents
2 Min Read

Daily US Times: Germany has rejected a US-backed proposal to waive patents on coronavirus vaccines, saying they were not hindering production of the jabs.

The German government said “the protection of intellectual property is a source of innovation and must remain so”.

Earlier, the European Union said it was ready to talk about the waive, and some states gave it their full backing.

Supporters of the plan say that the decision will allow more manufactures to produce the life-saving vaccines, adding that this will increase access to jabs in poorer countries.

But opponents of the plan, including drug makers, say it may not have the desired effect.

The idea was originally proposed by South Africa and India, who have been leading a group of about 60 countries at the World Trade Organization (WTO) – an intergovernmental body that promotes global commerce.

The group of countries is pushing for the temporary removal of intellectual property protections on vaccines.

The proposal was met with strong opposition from the previous Donald Trump administraton in the US, as well as the UK and the EU.

But this week, it gained momentum after the US backed it.

WTO head Ngozi Okonjo-Iweala told in an interview with BBC that she welcomed US support for the vaccine waiver. She said members should negotiate a pragmatic agreement over Covid-19 vaccine production because the current inequity was “not right”.

You may read: US backs waiver on Covid vaccine intellectual property